Prognostic and monitoring value of circulating tumor DNA at multiple clinical time points in breast cancer

Key Points

• Circulating tumor DNA levels correlate with clinical outcomes in breast cancer, indicating prognostic value.
• The study finds that monitoring circulating tumor DNA at multiple time points enhances tracking tumor burden.
• Assessment involved analyzing patient samples over various clinical stages to evaluate tumor dynamics.
• Implications indicate the potential for circulating tumor DNA to refine patient management and treatment strategies.